News

Merck will examine magentic beads coated with CardioGenics’ silver-coating and polymer encapsulation processes while refining encapsulation of the beads. The silver-coating technology of the CardioGenics enhances the signaling

The court found Actavis and co-defendant Actavis Elizabeth to have misrepresented its drug prices to Medicaid. The decision came after Florida-based pharmacy Ven-a-Care filed a whistleblower lawsuit under

The web-based PILOT MES/WDS production management system from FELTEN is expected to increase Lonza’s fermentation capacities by 50%. Lonza’s investment in the new multi-product manufacturing facility was necessary

Optimer said fidaxomicin is the first in a new class of antibiotics called macrocycles, which inhibit the bacterial enzyme RNA polymerase, resulting in the rapid killing of C

For the fourth quarter of 2010, the company posted a net income of $236m, or $0.15 per diluted share, compared to a net loss of $1.07bn, or $0.71

The company also reported that the first patient within the trial has been successfully genotyped and treatment has been initiated. LGC is collaborating with researchers from six European

Immunocytokine hu14.18-IL2 – an investigational antibody-based biologic, met drug development endpoints in a Phase II study involving certain paediatric neuroblastoma subjects, following which it has progressed to a

The formula is the latest addition to the Nestle Peptamen product family. Nestle HealthCare Nutrition has developed it with a unique protein-to-calorie ratio to help meet the protein

The research collaboration will start with the examination of the seven transporters cited by the International Transporter Consortium and the FDA as the most clinically relevant to transporter-related